"Not old medicine" was checked

The letter said that a few days ago, the media reflected that the operator illegal operation of "not old medicine" situation, it is learned that the main component of "non-old medicine" is niacinamide mono nucleic acid (NMN) or as raw material production, individual to tablet candy and other common forms of existence, the main publicity "anti-aging, repair DNA, prevent Alzheimer's disease" and other roles.
, NMN has not obtained the license of medicine, health food, food additives and new food raw materials in China, that is, NMN can not be produced and operated as food.
to this end, I now ask your province to conduct a comprehensive inspection of food operators in the jurisdiction, found that there are illegal acts, please promptly verify and investigate and punish according to law, the relevant inspection situation please report to us from February 1.
is NMN? Public information shows that NMN is short for niacinamide mononucleotide, is an inherent substance in the human body, but also rich in some fruits and vegetables, NMN has important physiological functions on human cells, can be naturally synthesized in cells.
NMN is a prelude to synthetic NAD plus in human body, and its physiological function is mainly reflected by raising the level of NAD plus.
NAD plus also known as coenzyme I. , full name niacinamide adenine dinucleotide, NAD plus in cells, not only as coenzyme but also as a base for a variety of signal reactions, involved in hundreds of reactions.
a 2016 paper by scientists at the University of Washington School of Medicine, the concentration of NMN in the blood gradually increased within 10 minutes after mice ingested dissolved NMN drinking water, and within 30 minutes, NMN circulated into multiple tissues and synthesized NAD plus in tissues to raise NAD-plus levels.
, NMN is considered an anti-aging health care product in the industry and is even known as a "life-long medicine".
In July 2020, Jindawei, known as the "Longevity Drug" leader, had its holding subsidiary Doctor's Best online a Dortberg NMN product ushered in a half-month market value of about 16 billion boom, by the Dortbes NMN products on the line, when the concept of "Longevity Drug" all the way up, including Yaben Chemical, Red Sun, brother technology have received a number of gains.
According to CITIC Securities estimates, the global anti-aging market size in 2019 is 190 billion U.S. dollars, up 8.3% YoY; , 25-44 years of age take 1 capsule per day, 45 years of age and above take 2 capsules per day), NMN per coverage of 1% of the domestic health care products market, the corresponding market size of about 30.4 billion yuan, with the future market of anti-aging products continue to promote, if NMN can cover the current health care products population of 3% of the scale, its market size is expected to reach 100 billion.
's current NMN market is mainly dominated by Japan Emerging and, herbalmax of the United States, and Gene Harbor, Hong Kong, China, after Tmall data showed that the three manufacturers of NMN products have high praise, praise rate of 96% and above.
addition, Gene Harbor also by virtue of NMN products to obtain the 2019 JD.com nutrition and health industry stores double eleven, double twelve sales first.
very attractive market so that many domestic enterprises competing layout, it is understood that the domestic participation in NMN research and development enterprises in addition to Jindawei, including Fengyuan Pharmaceuticals, Yaben Chemical and so on.
Fengyuan Pharmaceutical Co., Ltd. is mainly involved in 28.4% of the subsidiary Jiangsu Integrity Pharmaceutical Co., Ltd. to participate in NMN products related technology research and development, but there is currently no sales of the product.
Yaben Chemical is in October 11, 2019 issued an announcement to participate in NMN product development, referring to "cultivating new profit growth points, the development and production of NMN and other bioenzyme preparations and related biotechnology products", and later in the interactive platform said that the NMN project is one of the company's Shangyu base enzyme preparations and API projects, the current Shangyu base is in the process of construction.
also have some companies with industrial chain-related product development and sales, such as brother technology, Red Sun subsidiary Ruibang Bio and so on.
, however, there are industry sources who caution that consumers and investors need to be cautious about the safety and effectiveness of NMN products as they stand.
In accordance with China's regulations, NMN belongs to the new resources (it is not a drug), in order to be approved as a health care products in China must go through clinical trials, there is currently no NMN products in China officially approved for listing, and the future of the product approved for listing in China is also very difficult, which is why many "longevity drugs" through cross-border e-commerce as a sales platform.